SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-24-002210
Filing Date
2024-02-29
Accepted
2024-02-29 17:04:43
Documents
7
Effectiveness Date
2024-02-29

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20240229xs8.htm S-8 121886
2 EX-5.1 tmb-20240229xex5d1.htm EX-5.1 15105
3 EX-23.1 tmb-20240229xex23d1.htm EX-23.1 2074
4 EX-FILING FEES tmb-20240229xexfilingfees.htm EX-FILING FEES 28481
5 GRAPHIC tmb-20240229xex5d1002.jpg GRAPHIC 8986
6 GRAPHIC tmb-20240229xex5d1003.jpg GRAPHIC 4874
7 GRAPHIC tmb-20240229xex5d1005.jpg GRAPHIC 699
  Complete submission text file 0001558370-24-002210.txt   189143
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277541 | Film No.: 24704921
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)